Dr. Sabine Mueller, MD, PhD, MAS
Claim this profileUniversity of California, San Francisco
Expert in Brain Tumor
Studies Relapse
22 reported clinical trials
36 drugs studied
Area of expertise
1Brain Tumor
Global LeaderH3.3K27M positive
H3K27M positive
H3K27 positive
2Relapse
H3K27 positive
Stage I
Stage II
Affiliated Hospitals
Clinical Trials Sabine Mueller, MD, PhD, MAS is currently running
ONC206 + Radiation Therapy
for Brain Tumor
This trial studies the effects of ONC206, a new drug that stresses out cancer cells to kill them, in children and young adults with difficult-to-treat brain tumors. The drug can be used alone or with radiation therapy. ONC206 is related to ONC201, which has shown promise in treating certain types of brain tumors.
Recruiting1 award Phase 127 criteria
Individualized Treatment
for Medulloblastoma
The current study will use a new treatment approach based on the molecular characteristics of each participant's tumor. The study will test the feasibility of performing real-time drug screening on tissue taken during surgery, and of having a specialized tumor board assign a treatment plan based on the results of this screening and genomic sequencing. The aim of this trial is to allow every child and young adult with medulloblastoma to receive the most effective and least toxic therapies currently available, and will pave the way for improved understanding and treatment of these tumors in the future.
Recruiting1 award N/A
More about Sabine Mueller, MD, PhD, MAS
Clinical Trial Related7 years of experience running clinical trials · Led 22 trials as a Principal Investigator · 11 Active Clinical TrialsTreatments Sabine Mueller, MD, PhD, MAS has experience with
- Nivolumab
- ONC201
- Fimepinostat
- Therapeutic Conventional Surgery
- Tovorafenib/DAY101
- Specialized Tumor Board Recommendation
Breakdown of trials Sabine Mueller, MD, PhD, MAS has run
Brain Tumor
Relapse
Brain Cancer
Diffuse Intrinsic Pontine Glioma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Sabine Mueller, MD, PhD, MAS specialize in?
Sabine Mueller, MD, PhD, MAS focuses on Brain Tumor and Relapse. In particular, much of their work with Brain Tumor has involved H3.3K27M positive patients, or patients who are H3K27M positive.
Is Sabine Mueller, MD, PhD, MAS currently recruiting for clinical trials?
Yes, Sabine Mueller, MD, PhD, MAS is currently recruiting for 11 clinical trials in San Francisco California. If you're interested in participating, you should apply.
Are there any treatments that Sabine Mueller, MD, PhD, MAS has studied deeply?
Yes, Sabine Mueller, MD, PhD, MAS has studied treatments such as Nivolumab, ONC201, Fimepinostat.
What is the best way to schedule an appointment with Sabine Mueller, MD, PhD, MAS?
Apply for one of the trials that Sabine Mueller, MD, PhD, MAS is conducting.
What is the office address of Sabine Mueller, MD, PhD, MAS?
The office of Sabine Mueller, MD, PhD, MAS is located at: University of California, San Francisco, San Francisco, California 94143 United States. This is the address for their practice at the University of California, San Francisco.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.